Company
Orion Biotechnology
Unlocking the Therapeutic Potential of Metabolic GPCRs
Also known as Orion Biotechnology Canada, Ltd
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Legal name
- Orion Biotechnology Canada, Ltd
- orionbiotechnology.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Orion Biotechnology is unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules.
Funding snapshot
- Total raised
- $17.3MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $6.8M2024-07-08
Funding rounds
- Round, 2024
- $6.8M2024-07-08, SEC form D sold, 34 investors
- Round, 2021
- $9.9M2021-05-28, SEC form D sold, 142 investors
- Round, 2020
- $605K2020-09-24, SEC form D sold, 11 investors
Loading relationship preview